PLX73086

Plexxikon MOA PLX73086

Targeted Indication Status Sites link to clinicaltrials.gov

Solid Tumors

Phase 1

Scottsdale, AZ
San Antonio, TX
Detroit, MI

NCT02673736

These compounds and/or uses are investigational and have not been approved by the FDA or any other regulatory authority for the uses under investigation. Image above depicts proposed targeted pathway of the investigational agent(s) in the targeted indication.

Quail DF, Joyce JA. Nat Med. 2013; 19(11); 1423-37.
Data on file.